CRGX(CRGX)
CRGX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $2M | $193M | $304M | $2M |
| Low | $2M | $193M | $304M | $2M |
| High | $2M | $193M | $304M | $2M |
| EBITDA Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EBIT Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Net Income Avg | $-75M | $-53M | $-51M | $-39M |
| Low | $-128M | $-77M | $-51M | $-39M |
| High | $-23M | $-29M | $-51M | $-39M |
| EPS Avg | $-1.52 | $-1.16 | $-1.14 | $-0.87 |
| Low | $-2.85 | $-1.70 | $-1.14 | $-0.87 |
| High | $-0.50 | $-0.65 | $-1.14 | $-0.87 |
| Analysts (Rev / EPS) | 2 / 4 | 3 / 3 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2M | $4M | — | — | — | — |
| Low | $2M | $4M | — | — | — | — |
| High | $2M | $4M | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Net Income Avg | $-13M | $-27M | $-21M | $-17M | $-20M | $-16M |
| Low | $-13M | $-27M | $-21M | $-17M | $-20M | $-16M |
| High | $-13M | $-27M | $-21M | $-17M | $-20M | $-16M |
| EPS Avg | $-0.27 | $-0.56 | $-0.43 | $-0.35 | $-0.42 | $-0.34 |
| Low | $-0.27 | $-0.56 | $-0.43 | $-0.35 | $-0.42 | $-0.34 |
| High | $-0.27 | $-0.56 | $-0.43 | $-0.35 | $-0.42 | $-0.34 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | — / 1 | — / 1 | — / 1 | — / 1 |